Breast Cancer

Breast cancer survivor Dr. Sheri Prentiss discusses shifting oncology care from a "wait and see" approach to early lymphedema intervention and advocacy.

Dr. Reshma Jagsi discusses optimizing breast cancer care by safely de-escalating surgery and radiation using patient-centered communication

Physician Dr. Sheri Prentiss advocates for baseline measurements and proactive surveillance to detect and treat breast cancer-related lymphedema early.

Dr. Sara Nunnery and Dr. Neil Iyengar discuss metabolic health, GLP-1s and prescribing exercise to improve outcomes for breast cancer survivors.

Following her breast cancer diagnosis, Guerdy Abraira utilized genomic testing to gain clarity on her treatment path.

Learn about inflammatory breast cancer (IBC) diagnosis, aggressive treatment paths, and side effects to better navigate your journey and care plan.

Although I know better, I gardened in a sleeveless shirt and ended up with a poison ivy rash on my lymphedema limb. This time, I was lucky. Hopefully I will follow my own advice and avoid tempting fate next time.

A new study shows Signatera ctDNA testing may identify older patients with ER+/HER2- breast cancer who can manage their care without invasive surgery.

Eleven years with Stage 4 breast cancer, all on the first line of treatment. It isn’t chronic, but what is it?

A phase 3 trial finds anbenitamab and docetaxel improve response rates in patients with HER2-positive breast cancer and offer a safer delivery.

The 49th Annual Miami Breast Cancer Conference recently hosted a cornerstone event for the advocacy community: the CURE Educated Patient® Breast Cancer Summit.

Learn about Ductal Carcinoma in Situ (DCIS), its diagnosis, treatment options and side effects. Empower yourself with information to navigate this journey with confidence.

Experts highlight rising cancer rates in younger adults and the need for tailored support, treatment and survivorship care across the continuum.

So many friends I have met along the way wanted so badly to live and they weren't able to. They didn't lose and I didn't win. We all walked through something really hard and got different outcomes.

Dr. Wendy Woodward discussed the transformative rise of hypofractionated radiation.

Dr. Hope Rugo and advocate Jonise Louis discuss new ADCs, biomarker testing, and patient-centered dosing for metastatic triple-negative breast cancer.

The FOURLIGHT-1 study found that atirmociclib plus Faslodex significantly improved progression-free survival in patients with HR+/HER2- metastatic breast cancer.

A phase 3 trial update for GLSI-100 shows a recurrence rate of less than 1% per year in patients with HER2-positive breast cancer after immunization.

Survivor Casey Liening discusses her metastatic breast cancer journey, reaching NED, and why a stage 4 diagnosis is a beginning, not a death sentence.

Dr. Don S. Dizon presented information on pregnancy with a breast cancer diagnosis and what patients should know.

A daughter’s cancer journey shows that survivorship is filled with constant waiting—from tests and treatment to life milestones — where each result can bring relief or fear.

Learn about male breast cancer, including common symptoms, diagnostic tests and how hormone therapy or surgery is used to treat this rare disease.

Dr. Anastasia Tousimis explores the feasibility, risks and surgical techniques for performing NSM in radiated patients to ensure oncologic safety.

That’s what I need to remember: Not made-up scenarios, but that if I’m open, truly open, to whatever life has in store, it will be OK.

A study of 922 patients shows the Aida test predicts 10-year recurrence risk and helps guide radiation decisions for invasive breast cancer.